Please note - this article was originally published on the id21 website which has now closed. This and other articles produced by id21 were archived by Eldis in 2009 and are not actively maintained. If you find links and references which are no longer valid please email eldis@ids.ac.uk.
When it started, Thailand’s universal health coverage scheme excluded treatment for end-stage renal disease on economic grounds. This had serious implications for poorer patients who could not afford expensive, life-saving treatment, and contradicted the principles of equity and protection from financial risk fundamental to the scheme.
Research from the Thai Ministry of Public Health and the London School of Hygiene and Tropical Medicine assesses the medical and economic impacts of withholding free treatment for end-stage renal disease (ESRD). The authors offer alternatives that could help balance public policy goals of efficiency and equity.
Governments in low- and middle-income countries with limited health resources face the difficult decision of what to include in national health care benefit packages. Budget limitations, political pressure and public demand also influence these decisions. Thailand’s universal coverage (UC) scheme was set up in 2001 and covers 75 percent of the population.
Evidence suggested renal replacement therapy (RRT) was not cost-effective and could consume over 12 percent of national health expenditure. Therefore access to RRT for UC members depended on their ability to pay. The researchers studied 20 households affected by ESRD in urban and rural areas of Nakorn Ratchasima province. Findings included:
Excluding RRT from the health care scheme compromised UC policy goals. It was inequitable as beneficiaries under the two other public insurance schemes, Social Health Insurance and Civil Servant Medical Benefit Scheme, had full access to all RRT services. Since patients and their relatives were affected by medical costs, they were not protected from financial risk.
The Thai government should reconsider its decision not to support RRT, consulting with all major concerned groups. The researchers suggest four alternatives:
Source(s):
‘The Implications of Benefit Package Design: The Impact on Poor Thai
Households of Excluding Renal Replacement Therapy’, Journal of International
Development Vol.21, Issue.2, pages 291 to 308, by Phusit Prakongsai, Natasha
Palmer, Preecha Uay-Trakul, Viroj Tangcharoensathien and Anne Mills, 2009
Funded by: World Health Organization
id21 Research Highlight: 1 June 2009
Further Information:
Phusit Prakongsai
International Health Policy Program
Ministry of Public Health
Muang District
Nonthaburi Province
Thailand 11000
Tel:
+66 2 590 2366
Fax:
+66 2 590 2385
Contact the contributor: phusit@ihpp.thaigov.net
International Health Policy Program, Ministry of Public Health, Thailand
Other related links:
'Prioritising reproductive health services in Thailand'
'Any volunteers? Extending voluntary health insurance in Vietnam'
'Health care reforms in Georgia: at what price?'
'Join the club: promoting enrolment in community health insurance in
Burkina Faso'
'Informal health insurance in Rwanda: creating greater equity?'
'Universal coverage of health services: lessons from middle-income
countries'
'Financing mental health services in low- and middle-income countries'